The pathogenesis of BPH is complex and may be related to the balance in cell proliferation and apoptosis [15], the androgen receptor [16], epithelial mesenchymal transformation [17] and estrogen and androgen imbalance [18], and the molecular mechanisms underlying the clinical phenotype have not yet been fully revealed [19]. Here, AR is linked to benign prostatic hyperplasia.